Pharmacoeconomic analysis of combination of daclatasvir and sofosbuvir in treatment of chronic hepatitis C(genotype 3) in the Russian Federation: among treatmentexperienced patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.